MONDAY, March 27, 2023 (HealthDay News) — Children with autism are less likely than their peers to receive important vision screening despite a high risk for serious eye disorders, researchers report. Only about 36% of children with autism spectrum disorder (ASD) completed vision screenings during their health checkups, a newContinue Reading

WEDNESDAY, March 22, 2023 (HealthDay News) – A drug-resistant bacteria linked to recalled eye drops has now killed three people. The U.S. Centers for Disease Control and Prevention reported Tuesday that infections with Pseudomonas aeruginosa had led to two additional deaths. In all, 68 people have become infected in 16Continue Reading

TUESDAY, March 7, 2023 (HealthDay News) — U.S. Federal health officials have issued recall notices for two more brands of eyedrops. In the latest round of recalls, the U.S. Food and Drug Administration posted notices after the companies voluntarily pulled several lots of their eyedrops from the market. These recallsContinue Reading

MONDAY, March 6, 2023 (HealthDay News) — An outbreak of serious bacterial infections in 13 U.S. states linked to use of artificial tears has prompted experts to offer tips for keeping dry eyes safe. Five of the 58 people infected with Pseudomonas aeruginosa had vision loss, and one person died,Continue Reading

WEDNESDAY, Feb. 1, 2023 (HealthDay News) — U.S. health officials are investigating whether a specific brand of over-the-counter eyedrops are behind one death and dozens of bacterial infections in several states. The infections have not been traced to preservative-free EzriCare Artificial Tears, but a majority of people who became illContinue Reading

THURSDAY, Dec. 8, 2022 (HealthDay News) – Lasik eye surgery is a common vision-correcting procedure that many Americans view as safe and effective, but the U.S. Food and Drug Administration has now drafted guidance that warns of potential complications. Although many patients are happy with the results after surgery, theContinue Reading

WEDNESDAY, Dec. 7, 2022 (HealthDay News) — One of the two most common drugs used to treat age-related macular degeneration (AMD) appears better than the other, a new, small study suggests. Among 106 patients with “wet” age-related macular degeneration, 50% of those treated with aflibercept (Eylea) could be weaned offContinue Reading